Why the medical community is renaming PCOS to reflect its true metabolic nature

Health · Published 3 October 2026 Swipe more like this →

In short: Long known as polycystic ovary syndrome, this condition is being rebranded as polyendocrine metabolic ovarian syndrome. This shift acknowledges that the disorder is not merely a reproductive issue, but a complex systemic condition driven by insulin resistance and hormone imbalances that affect health far beyond the ovaries.

Polyendocrine metabolic ovarian syndrome (PMOS), formerly recognized as polycystic ovary syndrome, is a prevalent hormonal disorder affecting approximately one in eight women globally. While historical focus centered on the ovaries—specifically the presence of immature follicles—the new terminology emphasizes the broader metabolic and endocrine dysfunction at play. The condition is primarily characterized by hyperandrogenism, where the body produces or experiences excessive activity of androgen hormones, and insulin resistance, which disrupts the body’s ability to regulate blood sugar effectively.

The clinical presentation of PMOS is highly variable, often emerging during puberty. Diagnosis typically requires at least two of three core features: irregular or absent menstrual cycles, clinical or biochemical signs of high androgen levels, or the presence of multiple small follicles on the ovaries. Beyond these reproductive markers, the condition is frequently associated with hirsutism, acne, and weight gain. Because insulin resistance is a central driver, many individuals also experience metabolic complications, including an increased risk of type 2 diabetes, cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease.

Recent research is beginning to uncover the molecular mechanisms behind this systemic complexity. Studies using systems genetics have identified specific molecular drivers, such as the splicing factor SF3B1 and IGFBP2, which are linked to metabolic disease. In experimental models, inhibiting these factors has shown promise in reducing adiposity and normalizing androgen and insulin levels. These findings suggest that PMOS is a multifaceted condition that requires integrated management, moving away from a narrow reproductive focus toward a comprehensive approach that addresses long-term cardiometabolic health, mental well-being, and hormonal regulation.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• Hyperandrogenism is more than just high hormone levels; it is a complex metabolic state.
• Premenstrual dysphoric disorder is a chronic, severe condition, not just typical premenstrual syndrome.
• Ovarian cancer risk tracks how many times a woman has ovulated
• Why metabolic syndrome is a silent threat hiding in plain sight
• Why three out of four women experience premenstrual syndrome and how it works
• Is post-nasal drip a real medical condition or just a normal bodily function?
• The invisible space that allows your lungs to move
• The brain's back end can swell when blood pressure breaks a barrier
• Why that satisfying pop is actually the worst thing you can do for your skin
• Why your arms might feel too short for reading as you hit forty
• How your abdomen becomes a living filter for life-sustaining dialysis
• The brain-eating amoeba is rare, but its path to the central nervous system is precise.

More in Morbidity · More in Health · Latest · A–Z · All topics